Surgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 4
NCT ID: NCT02204995
Last Updated: 2016-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
62 participants
INTERVENTIONAL
2014-09-30
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators' hypothesis is that an LRTI can be of additional value in patients with stage 4 osteoarthritis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 2-3
NCT02204488
Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy
NCT03558204
Trapeziectomy vs. Trapeziometacarpal Limited Excision for Thumb Base Osteoarthritis
NCT04210687
Outcomes of Treatment for Trapeziometacarpal Osteoarthritis
NCT01724853
Proprioceptive Thumb Exercises Program in Patients With Carpometacarpal Joint Osteoarthritis
NCT04738201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trapeziectomy with LRTI
Trapeziectomy with Ligament Reconstruction and Tendon Interposition
Trapeziectomy with LRTI
Trapeziectomy with Ligament Reconstruction and Tendon Interposition
Trapeziectomy
Trapeziectomy
Trapeziectomy
Trapeziectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trapeziectomy with LRTI
Trapeziectomy with Ligament Reconstruction and Tendon Interposition
Trapeziectomy
Trapeziectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 40 years of age or more
* Symptomatic trapeziometacarpal osteoarthritis
* Eaton \& Glickel stage 4
Exclusion Criteria
* Participation in randomized clinical trial for trapeziometacarpal osteoarthritis with contralateral hand.
* Secondary trapeziometacarpal osteoarthritis as result of trauma, rheumatoid arthritis, systemic lupus or gout.
* Symptomatic carpal tunnel syndrome in same hand.
* Symptomatic Quervain's tenosynovitis in same hand.
* Neurological or other disorders of the affected side that can influence postoperative rehabilitation.
* Insufficient knowledge of Dutch language.
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isala
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ramon de Wildt
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeroen H. van Uchelen, MD
Role: STUDY_CHAIR
Isala
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isala Hospital
Zwolle, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL48197.075.14
Identifier Type: REGISTRY
Identifier Source: secondary_id
NL48197.075.14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.